59 research outputs found
Single-Atom Resolved Fluorescence Imaging of an Atomic Mott Insulator
The reliable detection of single quantum particles has revolutionized the
field of quantum optics and quantum information processing. For several years,
researchers have aspired to extend such detection possibilities to larger scale
strongly correlated quantum systems, in order to record in-situ images of a
quantum fluid in which each underlying quantum particle is detected. Here we
report on fluorescence imaging of strongly interacting bosonic Mott insulators
in an optical lattice with single-atom and single-site resolution. From our
images, we fully reconstruct the atom distribution on the lattice and identify
individual excitations with high fidelity. A comparison of the radial density
and variance distributions with theory provides a precise in-situ temperature
and entropy measurement from single images. We observe Mott-insulating plateaus
with near zero entropy and clearly resolve the high entropy rings separating
them although their width is of the order of only a single lattice site.
Furthermore, we show how a Mott insulator melts for increasing temperatures due
to a proliferation of local defects. Our experiments open a new avenue for the
manipulation and analysis of strongly interacting quantum gases on a lattice,
as well as for quantum information processing with ultracold atoms. Using the
high spatial resolution, it is now possible to directly address individual
lattice sites. One could, e.g., introduce local perturbations or access regions
of high entropy, a crucial requirement for the implementation of novel cooling
schemes for atoms on a lattice
Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML)
Antiapoptotic members of the bcl-2 family have recently been implicated in the pathogenesis of chronic myeloid leukemia (CML), a hematopoietic neoplasm associated with the BCR/ABL oncogene. We have examined expression of MCL-1 in primary CML cells and BCR/ABL-transformed cell lines. Independent of the phase of disease, isolated primary CML cells expressed myeloid cell leukemia-1 (mcl-1) mRNA and the MCLA protein in a constitutive manner. The BCR/ABL inhibitor imatinib (=ST1571) decreased the expression of MCLA in these cells. Corre- sponclingly, BCR/ABL enhanced mcl-1 promoter activity, mcl-1 mRNA expression, and the MCL-1 protein in Ba/F3 cells. BCR/ABL-dependent expression of MCL-1 in Ba/F3 cells was counteracted by the mitogen-activated protein-kinase/extracellular signal-regulated kinase (MEK) inhibitor, PD98059, but not by the phosphoinositide 3-kinase inhibitor, LY294002. Identical results were obtained for constitutive expression of MCL-1 in primary CML cells and the CML-derived cell lines K562 and KU812. To investigate the role of MCL-1 as a survival-related target in CML cells, mcl-1 siRNA and mcl-1 antisense oligonucleotides (ASOs) were applied. The resulting down-regulation of MCL-1 was found to be associated with a substantial decrease in viability of K562 cells. Moreover, the mcl-1 ASO was found to synergize with imatinib in producing growth inhibition in these cells. Together, our data identify MCL-1 as a BCR/ABL-dependent survival factor and interesting target in CML
PB2117 POMALIDOMIDE PLUS LOW-DEXAMETHASONE TREATMENT FOR≥ 1 YEAR IN PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA AND RENAL IMPAIRMENT: A SUBANALYSIS OF THE MM-013 PHASE 2 STUDY
PB2117 POMALIDOMIDE PLUS LOW-DEXAMETHASONE TREATMENT FOR≥ 1 YEAR IN PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA AND RENAL IMPAIRMENT: A SUBANALYSIS OF THE MM-013 PHASE 2 STUDY
Trypanothione Reductase: A Target Protein for a Combined In Vitro and In Silico Screening Approach
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms
-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasm
Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial
- …
